|  | eGFR annual average change (slope) from transplant to inclusion visit (ml/min/1.73m2/year) | p-value | |||||
---|---|---|---|---|---|---|---|---|
Time elapsed from transplant to inclusion visit | Â | N | Mean | SD | 25th percentile | Median | 75th percentile | Â |
[5 months; 1 year) | Females | 30 | −41.6 | 95.1 | −62.0 | −24.6 | 9.2 | 0.29355* |
Males | 92 | −22.3 | 50.0 | −54.0 | −14.8 | 9.6 | ||
Total | 122 | −27.1 | 64.2 | −56.1 | −16.9 | 9.5 | ||
[1 year; 2 years) | Females | 41 | − 5.5 | 27.3 | −23.2 | −6.9 | 3.6 | 0.1478** |
Males | 140 | −14.8 | 23.7 | −27.6 | −11.2 | −0.5 | ||
Total | 181 | −12.6 | 24.8 | −25.9 | −9.7 | −0.3 | ||
[2 years; 3 years) | Females | 33 | −6.8 | 17.7 | −12.7 | −5.1 | −0.2 | 0.54312* |
Males | 95 | −8.7 | 14.7 | −17.0 | −7.6 | 0.2 | ||
Total | 128 | −8.3 | 15.5 | −16.2 | −7.1 | −0.2 | ||
[3 years; 4 years) | Females | 28 | −4.6 | 8.1 | −10.3 | −5.9 | −1.0 | 0.40157* |
Males | 95 | −6.3 | 9.5 | −11.1 | −5.3 | 0.2 | ||
Total | 123 | −5.9 | 9.2 | −10.8 | −5.3 | −0.2 | ||
[4 years; 5.5 years] | Females | 25 | −3.7 | 11.1 | −9.0 | −3.7 | 2.6 | 0.94751* |
Males | 81 | −3.9 | 7.8 | −10.5 | −3.5 | 1.4 | ||
Total | 106 | −3.8 | 8.6 | −10.3 | −3.6 | 2.6 | ||
Total evaluable patients | Females | 157 | −12.2 | 46.6 | −16.7 | −5.9 | 2.6 | 0.87949* |
Males | 503 | −11.6 | 26.8 | −19.6 | −6.7 | 0.9 | ||
Total | 660 | −11.8 | 32.6 | −19.0 | −6.5 | 1.2 |